STOCK TITAN

BullFrog AI to Participate in the BTIG Virtual Biotechnology Conference

(Moderate)
(Neutral)
Tags
AI

BullFrog AI (NASDAQ: BFRG)/b) announced that its management team will participate in the , held July 28-29, 2026. The event gathers established and emerging healthcare companies for one-on-one investor meetings and thematic panel discussions.

BullFrog AI management will join one-on-one investor meetings on Wednesday, July 29, 2026. Investors interested in scheduling a meeting are advised to contact their BTIG representative.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – BFRG

-5.28%
2 alerts
-5.28% Session close to close
$11.77M Market Cap
0.7x Rel. Volume

In the Jul 23 session, BFRG declined 5.28%, reflecting a notable negative market reaction. Our momentum scanner triggered 2 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock moved -5.3% in the session following this news. Historical AI event 1043507 recorded a -6....
Analysis

The stock moved -5.3% in the session following this news. Historical AI event 1043507 recorded a -6.66% 24-hour reaction, demonstrating that AI-tagged announcements did not uniformly align with positive framing. This conference notice provides no financial update, leaving execution disclosure as a risk.

Key Figures

Article date: July 22, 2026 Conference dates: July 28-29, 2026 Investor meeting date: July 29, 2026
3 metrics
Article date July 22, 2026 Article dateline
Conference dates July 28-29, 2026 BTIG Virtual Biotechnology Conference
Investor meeting date July 29, 2026 One-on-one investor meetings

Previous AI Reports

5 past events · Latest: Jun 02 (Positive)
Same Type Pattern 5 events
Date Event Sentiment 24h Move Catalyst
Jun 02 Commercial leadership change Positive +9.6% New commercial leaders were appointed to support sales, business development, and scientific operations.
Apr 22 Nasdaq compliance regained Positive -6.7% Minimum stockholders’ equity was restored through ATM and equity-line sales.
Apr 14 AACR conference participation Neutral -3.8% Company planned an exhibition showcasing its AI-driven drug discovery workflow.
Apr 13 Business update Positive +18.6% Financing extended runway and the company launched bfARENAS while pursuing commercial activity.
Mar 30 Commercial agreement Positive +106.6% Agreement granted exclusive access to a target candidate for MDD discovery.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

AI-tagged announcements produced mostly positive reactions, although compliance and conference-participation news were followed by declines.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

GAITHERSBURG, Md., July 22, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), an AI company using three complementary capabilities to turn complex biomedical data into actionable insights, announces that the Company's management team will participate in the BTIG Virtual Biotechnology Conference being held on July 28-29, 2026.

BTIG’s virtual event will host established and emerging healthcare company management teams for one-on-one investor meetings and thematic panel discussions with industry leaders.

Management will be participating in one-on-one investor meetings on Wednesday, July 29th. Investors interested in scheduling a meeting with the BullFrog AI management team should contact their BTIG representative.

About BullFrog AI

BullFrog AI harnesses artificial intelligence and machine learning to advance pharmaceutical R&D and drug target discovery, providing AI-accelerated outputs that are optimized and human-validated. BullFrog AI operates through three complementary capabilities, deployable independently or as a combined platform: bfPREP™ for biology-aware data harmonization, bfLEAP® for causal AI analytics and patient subgroup discovery, and bfARENAS™ for structured, auditable decision support. The common thread across all three: every output is traceable, every analytical decision is logged, and every recommendation is designed to be reviewed and validated by the scientific team before it drives a decision.

For more information visit BullFrog AI at: https://bullfrogai.com.

About BTIG

BTIG is a global financial services firm specializing in institutional trading, investment banking, research and related brokerage services. With an extensive global footprint and more than 700 employees, BTIG, LLC and its affiliates operate out of 20 cities throughout the U.S., and in Europe, Asia and Australia. BTIG offers execution, expertise and insights for equities, equity derivatives, ETFs and fixed income, currency and commodities. The firm’s core capabilities include global execution, portfolio, electronic and outsource trading, transition management, investment banking, prime brokerage, capital introduction, corporate access, research and strategy, commission management and more.

Safe Harbor Statement

This press release contains forward-looking statements. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “could,” “will,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; our and our partners’ ability to market and sell our offerings and services, including BullFrog Data Networks™; our ability to maintain compliance with Nasdaq listing rules; and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this press release and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us. We are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this press release and other statements made from time to time by us or our representatives might not occur.

Contact:

Investors:
CORE IR
ir@bullfrogai.com

Media:
CORE PR
pr@bullfrogai.com


FAQ

What is BullFrog AI (NASDAQ: BFRG) announcing on July 22, 2026?

BullFrog AI announced its management will participate in the BTIG Virtual Biotechnology Conference on July 28-29, 2026. According to BullFrog AI, the team will attend one-on-one investor meetings and engage with healthcare-focused institutional investors.

When will BullFrog AI (BFRG) attend the BTIG Virtual Biotechnology Conference 2026?

BullFrog AI will participate in the BTIG Virtual Biotechnology Conference on July 28-29, 2026. According to BullFrog AI, its management will hold one-on-one investor meetings specifically on Wednesday, July 29, 2026, through BTIG’s virtual platform.

How can investors schedule a meeting with BullFrog AI (BFRG) at the BTIG biotech conference?

Investors can schedule a one-on-one meeting with BullFrog AI management by contacting their BTIG representative. According to BullFrog AI, meetings will be held during the BTIG Virtual Biotechnology Conference on July 28-29, 2026.

What type of event is the BTIG Virtual Biotechnology Conference featuring BullFrog AI (BFRG)?

The BTIG Virtual Biotechnology Conference is an online healthcare investor event. According to BullFrog AI, it features one-on-one investor meetings and thematic panel discussions with established and emerging healthcare company management teams.

Why is BullFrog AI (NASDAQ: BFRG) participating in the BTIG Virtual Biotechnology Conference?

BullFrog AI is joining the BTIG Virtual Biotechnology Conference to meet with investors in one-on-one meetings. According to BullFrog AI, the event connects healthcare company management teams with institutional investors via a virtual format.